CoAS_V1IS9_02

Popular Article
Probiotics: The Futuristic Alternative of Antibiotics?
Suryasarathi Kumar*, Ankita Pan, Isha Dey and Sneha Sarkar
Abstract
Probiotics are a natural alternative to antibiotics and are generally used to treat microbial infections that cause a variety of human and animal ailments. Doctors often prescribe antibiotics to treat diseases caused by microbial systems, such as bacteria or fungi. However, their excessive and improper usage has contributed to the rise in antimicrobial resistance, dysbiosis, or imbalance of the host microbiota despite antibiotics being the most well-known life-saving drugs. Antimicrobial resistance among microorganisms has emerged as a significant danger to global health, potentially resulting in millions of deaths annually in the past and future. It is imperative that antibiotic alternatives can be found and developed in light of these global problems because there is some evidence that probiotics can fight infections, control immunological responses, and maintain overall host health by re-establishing the balance of the gut microbiota. Probiotics can act as antibiotics if the gut microflora is identified and treated with plant extracts that solely stimulate these probiotic bacteria. If the treated bacteria exhibit more efficacy than the untreated bacteria, recombinant DNA technology can increase its effectiveness; as a result, it can be a more effective substitute for such high-dose antibiotics. The present study thoroughly explains the antimicrobial resistance problems associated with antibiotic use and the possibility of using probiotics as antibiotic alternatives.
Keywords
Probiotics, antibiotics, antimicrobial resistance, biotechnological strategies
Reference
Abushaheen, M. A., Muzaheed, Fatani, A. J., Alosaimi, M., Mansy, W., George, M., Acharya, S., Rathod, S., Divakar, D. D., Jhugroo, C., Vellappally, S., Khan, A. A., Shaik, J., & Jhugroo, P. (2020). Antimicrobial resistance, mechanisms, and its clinical significance. Disease-a-Month: DM, 66(6), 100971. https://doi.org/10.1016/j.disamonth.2020.100971
Aghamohammad, S., & Rohani, M. (2023). Antibiotic resistance and the alternatives to conventional antibiotics: The role of probiotics and microbiota in combating antimicrobial resistance. Microbiological Research, 267(127275), 127275. https://doi.org/10.1016/j.micres.2022.127275
Aghebati-Maleki, L., Hasannezhad, P., Abbasi, A., & Khani, N. (2021). Antibacterial, antiviral, antioxidant, and anticancer activities of postbiotics: a review of mechanisms and therapeutic perspectives. Biointerface Res. Appl. Chem, 12, 2629-2645. https://doi.org/10.33263/BRIAC122.26292645
Allen, H. K., Trachsel, J., Looft, T., & Casey, T. A. (2014). Finding alternatives to antibiotics: Finding alternatives to antibiotics. Annals of the New York Academy of Sciences, 1323(1), 91–100. https://doi.org/10.1111/nyas.12468
Azad, M. A. K., Sarker, M., & Wan, D. (2018). Immunomodulatory effects of probiotics on cytokine profiles. BioMed Research International, 2018, 8063647. https://doi.org/10.1155/2018/8063647
Bentley, R., & Bennett, J. W. (2003). What is an antibiotic? Revisited. Advances in Applied Microbiology, 52, 303–331. https://doi.org/10.1016/s0065-2164(03)01012-8
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023). Molecular mechanisms of antibiotic resistance revisited. Nature Reviews. Microbiology, 21(5), 280–295. https://doi.org/10.1038/s41579-022-00820-y
Etebu, E., & Arikekpar, I. (2016). Antibiotics: Classification and mechanisms of action with emphasis on molecular perspectives. Int. J. Appl. Microbiol. Biotechnol. Res, 4(2016), 90-101. https://www.bluepenjournals.org/ijambr/pdf/2016/October/Etebu_and_Arikekpar.pdf
Helmy, Y. A., Taha-Abdelaziz, K., Hawwas, H. A. E.-H., Ghosh, S., AlKafaas, S. S., Moawad, M. M. M., Saied, E. M., Kassem, I. I., &Mawad, A. M. M. (2023). Antimicrobial resistance and recent alternatives to antibiotics for controlling bacterial pathogens with an emphasis on foodborne pathogens. Antibiotics (Basel, Switzerland), 12(2), 274. https://doi.org/10.3390/antibiotics12020274
Jung, H.-M., Kim, S.-Y., Moon, H.-J., Oh, D.-K., & Lee, J.-K. (2007). Optimize culture conditions and scale-up to pilot and plant scales for vancomycin production by Amycolatopsis orientalis. Applied Microbiology and Biotechnology, 77(4), 789–795. https://doi.org/10.1007/s00253-007-1221-4
Kourkouta, L., Koukourikos, K., Iliadis, C., Plati, P., & Dimitriadou, A. (2018). History of antibiotics. Sumerian J Med Healthcare, 1, 51–55.
Kunyeit, L., K A, A.-A., & Rao, R. P. (2020). Application of probiotic yeasts on Candida species associated infection. Journal of Fungi (Basel, Switzerland), 6(4), 189. https://doi.org/10.3390/jof6040189
Laich, F., Fierro, F., & Martín, J. F. (2002). Production of penicillin by fungi growing on food products: identification of a complete penicillin gene cluster in Penicillium griseofulvum and a truncated cluster in Penicillium verrucosum. Applied and Environmental Microbiology, 68(3), 1211–1219. https://doi.org/10.1128/AEM.68.3.1211-1219.2002
Ma, F., Xu, S., Tang, Z., Li, Z., & Zhang, L. (2021). Use of antimicrobials in food animals and impact of transmission of antimicrobial resistance on humans. Biosafety and Health, 3(1), 32–38. https://doi.org/10.1016/j.bsheal.2020.09.004
Miao, V., Coëffet-LeGal, M.-F., Brian, P., Brost, R., Penn, J., Whiting, A., Martin, S., Ford, R., Parr, I., Bouchard, M., Silva, C. J., Wrigley, S. K., & Baltz, R. H. (2005). Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry. Microbiology (Reading, England), 151(Pt 5), 1507–1523. https://doi.org/10.1099/mic.0.27757-0
Oneill, J. (2016). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. http://www.advancedinvestor.com/resources/Research-Materials/Disease/UK_AMR_Report_Final.pdf
Papadopoulos, P., Angelidis, A. S., Papadopoulos, T., Kotzamanidis, C., Zdragas, A., Papa, A., Filioussis, G., &Sergelidis, D. (2019). Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in bulk tank milk, livestock and dairy-farm personnel in north-central and north-eastern Greece: Prevalence, characterization and genetic relatedness. Food Microbiology, 84(103249), 103249. https://doi.org/10.1016/j.fm.2019.103249
Petersen, C., & Round, J. L. (2014). Defining dysbiosis and its influence on host immunity and disease: How changes in microbiota structure influence health. Cellular Microbiology, 16(7), 1024–1033. https://doi.org/10.1111/cmi.12308
Pissowotzki, K., Mansouri, K., &Piepersberg, W. (1991). Genetics of streptomycin production in Streptomyces griseus: molecular structure and putative function of genes strELMB2N. Molecular & General Genetics: MGG, 231(1), 113–123. https://doi.org/10.1007/bf00293829
Raheem, A., Liang, L., Zhang, G., & Cui, S. (2021). Modulatory effects of probiotics during pathogenic infections with emphasis on immune regulation. Frontiers in Immunology, 12, 616713. https://doi.org/10.3389/fimmu.2021.616713
  • Published online
  • 19th February, 2024
 
How to Cite the Article
Kumar, S., Pan, A., Dey, I. and Sarkar, S. 2024. Probiotics: The Futuristic Alternative of Antibiotics? Chronicle of Aquatic Science 1(9): 15-21.
 
Copyright
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. 
  

CoAS_V1IS9_02

File Action
CoAS_V1IS9_02 Download